Newsroom

All News
  • All News
  • In the News
  • Press Releases
  • Publications
  • Events
Immunexpress.com

Immunexpress to Present SeptiCyte® RAPID Data at the Association for Molecular Pathology Annual Meeting

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced further SeptiCyte® RAPID data demonstrating performance, reproducibility and identification of fungal infections, in two poster presentations at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo on Nov. 16-20.   “Our SeptiCyte®...
AMP2020

Comparison of a Cartridge-Based Host Gene Expressions Test to a Manual Method for Use in the Diagnosis of Sepsis

SeptiCyte® RAPID test is a rapid, repeatable, reproducible, near-patient, immune-response sepsis diagnostic, providing accurate results in ~ 1 hr to differentiate sepsis from SIRS
AMP2020

In Silico Performance of a Rapid Sepsis Test in Patients with Candidemia

SeptiCyte® RAPID differentiated patients with candidemia from those with INSI/SIRS, not infected and healthy subjects  
Immunexpress.com

Immunexpress to Present SeptiCyte® RAPID Data at the Association for Molecular Pathology Annual Meeting

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that it will present data in two posters and host a workshop at the Association for Molecular Pathology (AMP) 2020 Annual Meeting & Expo taking place virtually on Nov. 16-20, 2020.   Details of...
SCCM

SCCM Podcast: Severe COVID-19 and Sepsis

Severe COVID-19 infection can be a form of viral sepsis with occasionally concomitant bacterial infection. Pamela M. Peeke MD, MPH, FACP, FACSM, is joined by Russell Miller, MD, MPH, FCCM, to discuss the definition of sepsis and overlap with case descriptions of patients with severe COVID-19, how experience with viral...
MedTech Innovation

Q&A: Sepsis detection technology that can triage COVID-19 patients

Ian Bolland caught up with Dr. Rolland Carlson, CEO of Immunexpress, to talk about a molecular diagnostic, SeptiCyte RAPID, which is used to detect sepsis and offers the potential to triage severe COVID-19 patients in the emergency department. Expand Briefly, tell us more about Immunexpress – how did the idea...
Immunexpress.com

Immunexpress Identifies and Validates Blood Transcriptomic Signatures for Discrimination of Viral and Bacterial Infections in the Emergency Department

Publication in BMC Medicine demonstrates the combination of SeptiCyte® TRIAGE and SeptiCyte® VIRUS can discriminate between bacterial and viral infections in Emergency Department patients SEATTLE, Sept. 23, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today new data in collaboration with researchers at...
Immunexpress.com

Immunexpress Presents Data on Clinical Validation of SeptiCyte® RAPID for Diagnosing Sepsis at e-ISICEM

Immunexpress, Inc., a medical diagnostic company focused on improving outcomes for suspected sepsis patients, today announced the presentation of analytical and clinical performance data for SeptiCyte® technology in two posters at the virtual e-ISICEM (International Symposium on Intensive Care and Emergency Medicine), from Sept. 15-18, 2020. The first poster, titled "Clinical...
360DX

Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch

Immunexpress and its partner Biocartis plan to introduce a new, rapid test for sepsis in Europe this quarter ahead of a potential US Food and Drug Administration 510(k) clearance for the assay later this year. The companies are positioning the test, called SeptiCyte Rapid, to triage COVID-19 patients who could...
SA_logo-V_CMYK

The Sepsis Alliance Summit

This September, Sepsis Alliance is proudly hosting the inaugural Sepsis Alliance Summit. Set to coincide with Sepsis Awareness Month and the annual Sepsis Heroes gala, the event will feature two days of learning and inspiration for healthcare providers, managers, policymakers, and industry leaders. Designed to explore an array of sepsis-related topics...
SA_logo-V_CMYK

9th Annual Sepsis Heroes Gala

Meet the 2020 Class of Sepsis Heroes From a grandfather, sepsis survivor, and advocate in North Carolina to a community hospital reducing sepsis mortality in Los Angeles, CA, this year’s Sepsis Heroes are making great strides in raising sepsis awareness and helping save lives in their communities and across the nation.  The 2020 Sepsis Heroes are:   Emanuel Rivers, MD, MPH, Vice Chairman and Director of Research in...
BMC Medicine_Blue 01_RGB

Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study

Abstract Background There is an urgent need to develop biomarkers that stratify risk of bacterial infection in order to support antimicrobial stewardship in emergency hospital admissions. Methods We used computational machine learning to derive a rule-out blood transcriptomic signature of bacterial infection (SeptiCyte™ TRIAGE) from eight published case-control studies. We...

If you are a member of the media, please contact:

Maggie Beller
Russo Partners
(646) 942-5631
maggie.beller@russopartnersllc.com